{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:17:40Z","timestamp":1790716660711,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37103","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T12:59:53Z","timestamp":1724849993000},"page":"e37103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Increased serum interferon activity in sarcoidosis compared to that in tuberculosis: Implication for diagnosis?"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6427-6765","authenticated-orcid":false,"given":"Benjamin","family":"Schrijver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"G\u00f6pfert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"La Distia Nora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikhwanuliman","family":"Putera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.A.N.","family":"Nagtzaam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja A.W.","family":"Smits te Nijenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique L.C.T.","family":"van Rijswijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josianne C.E.M.","family":"ten Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Martin","family":"van Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Dik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e37103_bib1","series-title":"Nature Reviews: Disease Primers","article-title":"Sarcoidosis (primer)","author":"Grunewald","year":"2019"},{"key":"10.1016\/j.heliyon.2024.e37103_bib2","volume":"2","author":"Pai","year":"2016","journal-title":"Tuberculosis. Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37103_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065202","article-title":"Tuberculosis: pathogenesis, current treatment regimens and new drug targets","volume":"24","author":"Alsayed","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37103_bib4","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1016\/j.jfo.2018.10.002","article-title":"Sarcoidosis","volume":"41","author":"Salah","year":"2018","journal-title":"J. Fr. Ophtalmol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37103_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccm.2015.08.009","article-title":"Ocular sarcoidosis","volume":"36","author":"Pasadhika","year":"2015","journal-title":"Clin. Chest Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37103_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ophtha.2006.05.074","article-title":"Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis","volume":"114","author":"Evans","year":"2007","journal-title":"Ophthalmology."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37103_bib7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MCP.0000000000000409","article-title":"Ocular sarcoidosis: new diagnostic modalities and treatment","volume":"23","author":"Yang","year":"2017","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37103_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.mayocpiqo.2019.04.006","article-title":"Clinical manifestations, diagnosis, and treatment of sarcoidosis","volume":"3","author":"Ungprasert","year":"2019","journal-title":"Mayo Clin Proc Innov Qual Outcomes."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37103_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005792-199701000-00005","article-title":"Ocular tuberculosis. A prospective study in a general hospital","volume":"76","author":"Bouza","year":"1997","journal-title":"Medicine (Baltim.)"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37103_bib10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.survophthal.2021.10.001","article-title":"Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis","volume":"67","author":"Alli","year":"2022","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e37103_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.527433","article-title":"Distinct miRNA gene expression profiles among the nodule tissues of lung sarcoidosis, tuberculous lymphadenitis and normal healthy control individuals","volume":"7","author":"Zhao","year":"2020","journal-title":"Front. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37103_bib12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1164\/rccm.201106-1143OC","article-title":"Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis","volume":"184","author":"Koth","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37103_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s42003-020-01318-0","article-title":"Lung gene expression signatures suggest pathogenic links and molecular markers for pulmonary tuberculosis, adenocarcinoma and sarcoidosis","volume":"3","author":"Chai","year":"2020","journal-title":"Commun. Biol."},{"issue":"20","key":"10.1016\/j.heliyon.2024.e37103_bib14","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.1073\/pnas.1121072109","article-title":"Common patterns and disease-related signatures in tuberculosis and sarcoidosis","volume":"109","author":"Maertzdorf","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37103_bib15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/IAE.0b013e31822d3a20","article-title":"Predictors for tubercular uveitis: a comparison between biopsy-proven cases of tubercular and sarcoid uveitis","volume":"32","author":"Babu","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.heliyon.2024.e37103_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajo.2021.01.025","article-title":"Clinical and multimodal imaging clues in differentiating between tuberculomas and sarcoid choroidal granulomas","volume":"226","author":"Agarwal","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e37103_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tube.2016.01.003","article-title":"Tuberculosis or sarcoidosis: opposite ends of the same disease spectrum?","volume":"98","author":"Agrawal","year":"2016","journal-title":"Tuberculosis"},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2024.e37103_bib18","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1016\/j.ijmyco.2016.09.031","article-title":"Common features of tuberculosis and sarcoidosis","volume":"5","author":"Mortaz","year":"2016","journal-title":"Int J Mycobacteriol"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37103_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12093194","article-title":"Sarcoidosis-related uveitis: a review","volume":"12","author":"Giorgiutti","year":"2023","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37103_bib20","doi-asserted-by":"crossref","first-page":"e993","DOI":"10.1016\/j.ijid.2013.03.019","article-title":"Diagnosis and treatment of tuberculous uveitis in a low endemic setting","volume":"17","author":"Vos","year":"2013","journal-title":"Int. J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37103_bib21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-\u03b3-Producing T-helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-helper type 1 cells","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37103_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01124-2017","article-title":"Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes","volume":"51","author":"Broos","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2024.e37103_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/438070","article-title":"Bronchoalveolar lavage fluid IFN-gamma+ Th17 cells and regulatory T cells in pulmonary sarcoidosis","volume":"2014","author":"Tondell","year":"2014","journal-title":"Mediators Inflamm"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37103_bib24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s10875-012-9817-6","article-title":"Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-gamma expression","volume":"33","author":"Richmond","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37103_bib25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mai.2001.113524","article-title":"Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases","volume":"107","author":"Miotto","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37103_bib26","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1183\/09031936.00089910","article-title":"T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis","volume":"38","author":"Kriegova","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2024.e37103_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.960266","article-title":"A transcriptomics-based meta-analysis identifies a cross-tissue signature for sarcoidosis","volume":"9","author":"Jiang","year":"2022","journal-title":"Front. Med."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37103_bib28","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1164\/rccm.201512-2419ED","article-title":"Th1, Th17, or Th17.1?","volume":"193","author":"Georas","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e37103_bib29","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37103_bib30","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1164\/ajrccm.162.5.9911113","article-title":"Increased levels of interleukin-18 in patients with pulmonary sarcoidosis","volume":"162","author":"Shigehara","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2024.e37103_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1381031","article-title":"Bioinformatic meta-analysis reveals novel differentially expressed genes and pathways in sarcoidosis","volume":"11","author":"van Wijck","year":"2024","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37103_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1742-1241.2005.00651.x","article-title":"Interferon-induced sarcoidosis","volume":"60","author":"Alazemi","year":"2006","journal-title":"Int. J. Clin. Pract."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37103_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.rhu.0000240035.67652.9d","article-title":"Interferon-induced sarcoidosis","volume":"12","author":"Doyle","year":"2006","journal-title":"J. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37103_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s535-002-8133-3","article-title":"Reactivation of sarcoidosis during interferon therapy","volume":"37","author":"Li","year":"2002","journal-title":"J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37103_bib35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archderm.141.7.865","article-title":"Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature","volume":"141","author":"Hurst","year":"2005","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.heliyon.2024.e37103_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00439-004-1099-5","article-title":"Association between IFNA genotype and the risk of sarcoidosis","volume":"114","author":"Akahoshi","year":"2004","journal-title":"Hum. Genet."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37103_bib37","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37103_bib38","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.heliyon.2024.e37103_bib39","article-title":"Interferon-Gamma improves macrophages function against M. tuberculosis in multidrug-resistant tuberculosis patients","volume":"2016","author":"Khan","year":"2016","journal-title":"Chemother Res Pract"},{"key":"10.1016\/j.heliyon.2024.e37103_bib40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.genom.8.080706.092315","article-title":"Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis","volume":"8","author":"Fortin","year":"2007","journal-title":"Annu Rev Genomics Hum Genet."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37103_bib41","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.imbio.2012.08.281","article-title":"Patients with inhibitory and neutralizing auto-antibodies to interferon-gamma resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseases","volume":"218","author":"Lee","year":"2013","journal-title":"Immunobiology"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37103_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076371","article-title":"Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand","volume":"8","author":"Wongkulab","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37103_bib43","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3201\/eid2206.151860","article-title":"Interferon-\u03b3 autoantibodies as predisposing factor for nontuberculous mycobacterial infection","volume":"22","author":"Valour","year":"2016","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37103_bib44","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1086\/380453","article-title":"Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity","volume":"38","author":"Doffinger","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37103_bib45","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20180325","article-title":"Type I interferons in tuberculosis: foe and occasionally friend","volume":"215","author":"Moreira-Teixeira","year":"2018","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37103_bib46","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1073\/pnas.091096998","article-title":"Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha\/beta","volume":"98","author":"Manca","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37103_bib47","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1172\/JCI40817","article-title":"Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte\/macrophage population","volume":"120","author":"Antonelli","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37103_bib48","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.4049\/jimmunol.1300146","article-title":"TPL-2-ERK1\/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production","volume":"191","author":"McNab","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e37103_bib49","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3389\/fimmu.2017.01633","article-title":"Type I interferons in the pathogenesis of tuberculosis: molecular drivers and immunological consequences","volume":"8","author":"Donovan","year":"2017","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37103_bib50","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41564-019-0578-3","article-title":"Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1Ra","volume":"4","author":"Ji","year":"2019","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37103_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon\u2010like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37103_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206073","article-title":"Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: a tool to stratify a high versus low risk of active tuberculosis?","volume":"13","author":"La Distia Nora","year":"2018","journal-title":"PLoS One"},{"issue":"7309","key":"10.1016\/j.heliyon.2024.e37103_bib53","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"issue":"10035","key":"10.1016\/j.heliyon.2024.e37103_bib54","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e37103_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2021.102127","article-title":"Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease","volume":"131","author":"Burel","year":"2021","journal-title":"Tuberculosis"},{"key":"10.1016\/j.heliyon.2024.e37103_bib56","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.925438","article-title":"Identification of biomarkers for sarcoidosis and tuberculosis of the lung using systematic and integrated analysis","volume":"26","author":"Zhao","year":"2020","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.heliyon.2024.e37103_bib57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fcimb.2019.00296","article-title":"Plasma type I IFN protein concentrations in human tuberculosis","volume":"9","author":"Llibre","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e37103_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101396","article-title":"Evaluation of a transcriptomic signature of tuberculosis risk in combination with an interferon gamma release assay: a diagnostic test accuracy study","volume":"47","author":"Mulenga","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37103_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytox.2020.100028","article-title":"Value of serum cytokine biomarkers TNF-alpha, IL-4, sIL-2R and IFN-gamma for use in monitoring bacterial load and anti-tuberculosis treatment progress","volume":"2","author":"Nie","year":"2020","journal-title":"Cytokine X"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37103_bib60","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211036832","article-title":"Serum levels of inhibitory costimulatory molecules and correlations with levels of innate immune cytokines in patients with pulmonary tuberculosis","volume":"49","author":"Zhao","year":"2021","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37103_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227636","article-title":"Diagnostic performance of serum interferon gamma, matrix metalloproteinases, and periostin measurements for pulmonary tuberculosis in Japanese patients with pneumonia","volume":"15","author":"Yamauchi","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37103_bib62","first-page":"17","article-title":"The value of serum interferon-gamma level in the differential diagnosis of active and inactive pulmonary tuberculosis","volume":"54","author":"K\u00f6ksal","year":"2006","journal-title":"Tuberk Toraks"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37103_bib63","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrmicro2236-c1","article-title":"Spectrum of latent tuberculosis - existing tests cannot resolve the underlying phenotypes","volume":"8","author":"Pai","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37103_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038083","article-title":"Sarcoidosis and tuberculosis cytokine profiles: indistinguishable in bronchoalveolar lavage but different in blood","volume":"7","author":"Thillai","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37103_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250255","article-title":"T-cell signature cytokines distinguish pulmonary sarcoidosis from pulmonary tuberculosis","volume":"53","author":"Jain","year":"2023","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37103_bib66","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4103\/ijo.IJO_2830_21","article-title":"Progress in the diagnosis of ocular sarcoidosis","volume":"70","author":"O'Keefe","year":"2022","journal-title":"Indian J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37103_bib67","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.7150\/thno.81488","article-title":"Diagnosis and biomarkers for ocular tuberculosis: from the present into the future","volume":"13","author":"Ludi","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.heliyon.2024.e37103_bib68","doi-asserted-by":"crossref","DOI":"10.1111\/aos.15093","article-title":"Serum CCL17 distinguishes sarcoid uveitis from TB-uveitis and QFT-negative uveitis","author":"Schrijver","year":"2022","journal-title":"Acta Ophthalmol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37103_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1196","article-title":"Inverse correlation between serum complement component C1q levels and whole blood type-1 interferon signature in active tuberculosis and QuantiFERON-positive uveitis: implications for diagnosis","volume":"9","author":"Schrijver","year":"2020","journal-title":"Clin Transl Immunology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37103_bib70","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/eye.2017.231","article-title":"Tuberculosis and other causes of uveitis in Indonesia","volume":"32","author":"La Distia Nora","year":"2018","journal-title":"Eye (Lond)."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37103_bib71","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/rheumatology\/keab688","article-title":"Serum interferon-alpha2 measured by single-molecule array associates with systemic disease manifestations in Sjogren's syndrome","volume":"61","author":"Huijser","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.heliyon.2024.e37103_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104736","article-title":"Transient anti-cytokine autoantibodies superimpose the hyperinflammatory response in Kawasaki disease and multisystem inflammatory syndrome in children: a comparative cohort study on correlates of disease","volume":"95","author":"Netea","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.heliyon.2024.e37103_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1381031","article-title":"Bioinformatic meta-analysis reveals novel differentially expressed genes and pathways in sarcoidosis","volume":"11","author":"van Wijck","year":"2024","journal-title":"Front. Med."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37103_bib74","article-title":"Sarcoid uveitis: an intriguing challenger","volume":"58","author":"Allegri","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.heliyon.2024.e37103_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2023.101189","article-title":"The immune response in tubercular uveitis and its implications for treatment: from anti-tubercular treatment to host-directed therapies","volume":"95","author":"Putera","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37103_bib76","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1167\/iovs.05-0966","article-title":"Elevated serum levels of CXCL9\/monokine induced by interferon-gamma and CXCL10\/interferon-gamma-inducible protein-10 in ocular sarcoidosis","volume":"47","author":"Takeuchi","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37103_bib77","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1167\/iovs.11-9244","article-title":"Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis","volume":"53","author":"Nagata","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37103_bib78","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1465-9921-14-121","article-title":"Interferon-inducible chemokines reflect severity and progression in sarcoidosis","volume":"14","author":"Su","year":"2013","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2024.e37103_bib79","first-page":"565","article-title":"Aqueous cytokine and chemokine analysis in uveitis associated with tuberculosis","volume":"18","author":"Ang","year":"2012","journal-title":"Mol. Vis."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37103_bib80","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1167\/iovs.17-23246","article-title":"Retinal pigment epithelial cells control early Mycobacterium tuberculosis infection via interferon signaling","volume":"59","author":"La Distia Nora","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e37103_bib81","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1167\/iovs.17-22462","article-title":"Autoreactive T cells in immunopathogenesis of TB-associated uveitis","volume":"58","author":"Tagirasa","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37103_bib82","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cyto.2013.07.010","article-title":"Plasma level of interferon \u03b3 induced protein 10 is a marker of sarcoidosis disease activity","volume":"64","author":"Geyer","year":"2013","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37103_bib83","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MCP.0000000000000403","article-title":"Transcriptome profiles in sarcoidosis and their potential role in disease prediction","volume":"23","author":"Schupp","year":"2017","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37103_bib84","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1089\/jir.2011.0101","article-title":"Interferons in autoimmune and inflammatory diseases: regulation and roles","volume":"31","author":"Choubey","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37103_bib85","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1093\/rheumatology\/keac698","article-title":"Serum IFNalpha2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort","volume":"62","author":"Wahadat","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.heliyon.2024.e37103_bib86","article-title":"IFN-\u03b3, should not be ignored in SLE","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37103_bib87","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/annrheumdis-2018-213386","article-title":"Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status","volume":"77","author":"Md Yusof","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.heliyon.2024.e37103_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.991394","article-title":"Sarcoidosis and autoimmunity: in the depth of a complex relationship","volume":"9","author":"Rizzi","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.heliyon.2024.e37103_bib89","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3389\/fimmu.2018.02427","article-title":"Complement component C1q as serum biomarker to detect active tuberculosis","volume":"9","author":"Lubbers","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37103_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132466","article-title":"Screening for differentially expressed proteins relevant to the differential diagnosis of sarcoidosis and tuberculosis","volume":"10","author":"Du","year":"2015","journal-title":"PLoS One"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024131349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024131349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:38:32Z","timestamp":1790714312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024131349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":90,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024131349"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37103","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased serum interferon activity in sarcoidosis compared to that in tuberculosis: Implication for diagnosis?","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37103"}}